Sharac, Jessica <br/><br/>
Pharmacoeconomic considerations in the treatment of multiple sclerosis.  [electronic resource] 

 -  Drugs  Sep 2010 
 - 1677-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1179-1950 
<br/><br/><label>Standard No.: </label>10.2165/11538000-000000000-00000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--economics<br/>Cost of Illness<br/>Economics, Pharmaceutical<br/>Glatiramer Acetate<br/>Humans<br/>Interferon beta-1a<br/>Interferon beta-1b<br/>Interferon-beta--economics<br/>Multiple Sclerosis--drug therapy<br/>Peptides--economics